Product Reports Resources Pricing Login Book a demo

Leo Cancer Care

Health Tech & Medtech · Horley, United Kingdom · Founded 2014

Stand-up CT scanner and radiotherapy system that reduces the cost of radiotherapy and improves cancer patient outcomes MoreLess

Leo Cancer Care is a medical technology company focused on developing and commercializing a new approach to radiation therapy. The company has developed a range of solutions for both photon and particle therapy that utilize an upright patient positioning system. This method challenges the conventional lie-down treatment approach, aiming to improve patient comfort and treatment accuracy.

The company's product portfolio includes the 'Marie' system, a particle therapy solution that integrates an upright patient positioning platform with a fan beam CT scanner. This system is designed to be 'beam agnostic', allowing for integration with existing fixed-beam radiation therapy technologies. By avoiding the need for large, rotating gantries, the company's solutions can offer significant cost savings to healthcare providers, potentially expanding access to advanced cancer care.

Leo Cancer Care operates in the global oncology market, with a focus on providing more effective and efficient radiotherapy options. The company is actively seeking regulatory clearance for its products, including a pending 510(k) decision from the FDA for its 'Marie' solution, which would allow for its commercialization in the United States.

Keywords: radiotherapy, oncology, particle therapy, photon therapy, medical devices, cancer treatment, upright positioning, patient care, healthcare technology, cost reduction

Company overview

Leo Cancer Care company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2014
Headquarters
Horley, United Kingdom
Employees
123
Open positions
9
Dealroom signal
83.8
client focusb2btechnologyDeep Techsub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorOncologysectorSpinoutsectorTech for Hospitals and ClinicssectorDT and LSsectorrio ai healthsectorrio AI medical devicessectoruk riosectoruk is8 life sciencessectorscience-based

Valuation & funding

Leo Cancer Care funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Sep 2025 $40M $160M Catalio Capital Management
SERIES COther financing Jun 2024 WARF Ventures · McLaren Health Care · Macmillan Cancer Support · EDB Singapore
SERIES BOther financing Jul 2021 $25M $101M Radiation Solutions · Yu Galaxy · Serra Ventures · WARF Ventures
GRANTOther financing Mar 2020 Undisclosed
SPINOUTOther financing Jan 2014 $0 University of Wisconsin-Madison · WARF Ventures
Showing 5 recorded eventsUnlock the complete deal history →

Growth signals

Leo Cancer Care website traffic

Latest recorded traffic for Leo Cancer Care is 6.6K monthly website visits, up 57.1% over the last three months. Leo Cancer Care's team grew 5.1% over the past year.

Latest monthly visits6.6K 3-month web change+57.1% 1-year team growth+5.1%
Monthly website visits47 observations · Jan 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Leo Cancer Care compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Leo Cancer Care's talent

Book a demo to see the people
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

15 investors on Leo Cancer Care's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 8 investors entered at this stage
Radiation Solutions
Yu Galaxy
Serra Ventures
WARF Ventures
Alumni Ventures
Asto CT
Junson Capital
Pureland Group Venture
Series B+ 6 investors entered at this stage
McLaren Health Care
Macmillan Cancer Support
EDB Singapore
Cone Health
Aviko Radiopharmaceuticals
Catalio Capital Management
Other known 1 additional known investor
University of Wisconsin-Madison

Global footprint

Where Leo Cancer Care has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States46.8%
🇬🇧 United Kingdom44.7%
🇸🇬 Singapore2.1%
🇯🇵 Japan1.1%
🇨🇭 Switzerland1.1%
Top 5 of 9 shown

In the news

Latest news about Leo Cancer Care

Recent press, funding announcements, and product moves mentioning Leo Cancer Care — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Leo Cancer Care

An AI-synthesized read of the highest-engagement posts about Leo Cancer Care on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Leo Cancer Care’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.